These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32853922)

  • 1. Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome.
    Park HR; Choi SJ; Joo EY; Allen RP
    Sleep Med; 2020 Nov; 75():81-87. PubMed ID: 32853922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
    Schneider J; Krafft A; Manconi M; Hübner A; Baumann C; Werth E; Gyr T; Bassetti C
    Sleep Med; 2015 Nov; 16(11):1342-1347. PubMed ID: 26498233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
    Bae H; Cho YW; Kim KT; Allen RP; Earley CJ
    Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
    Hornyak M; Scholz H; Kiemen A; Kassubek J
    Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment for restless legs symptoms and low serum ferritin in children with autism spectrum disorder.
    DelRosso LM; Reuter-Yuill LM; Cho Y; Ferri R; Mogavero MP; Picchietti DL
    Sleep Med; 2022 Dec; 100():488-493. PubMed ID: 36265207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of intravenous ferric carboxymaltose for treatment of restless legs syndrome: a multicenter, randomized, placebo-controlled clinical trial.
    Earley CJ; García-Borreguero D; Falone M; Winkelman JW
    Sleep; 2024 Jul; 47(7):. PubMed ID: 38625730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
    Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
    Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Repeated Dosing of Intravenous Ferric Carboxymaltose Alleviate Symptoms of Restless Legs Syndrome?
    Park HR; Choi SJ; Joo EY
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2018 Feb; 42():7-12. PubMed ID: 29458749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder.
    DelRosso LM; Ferri R; Chen ML; Kapoor V; Allen RP; Mogavero MP; Picchietti DL
    Sleep Med; 2021 Nov; 87():114-118. PubMed ID: 34562823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients.
    Lieske B; Becker I; Schulz RJ; Polidori MC; Kassubek J; Roehrig G
    Z Gerontol Geriatr; 2016 Oct; 49(7):626-631. PubMed ID: 26597718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.
    Bae H; Cho YW; Kim KT; Li X; Earley CJ
    Sleep Med; 2023 Sep; 109():128-131. PubMed ID: 37437492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2016 Sep; 25():16-23. PubMed ID: 27823710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.
    Trenkwalder C; Winkelmann J; Oertel W; Virgin G; Roubert B; Mezzacasa A;
    Mov Disord; 2017 Oct; 32(10):1478-1482. PubMed ID: 28643901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies.
    Yang X; Yang B; Ming M; Li S; Wang F; Zhu Z; Ji C; Long J; Hu F; Xu Z; Ren H; Liu B
    Sleep Med; 2019 Sep; 61():110-117. PubMed ID: 31395522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
    Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
    Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients.
    Qadri SN; Jamil S; Zahid S; Asghar T; Gillani SM; Qasim SA; Kambar T; Abideen ZU; Brohi U; Tareen SK; Tareen PK; Kumari S; Kumar S; Khatri M
    Sleep Med; 2024 Sep; 124():244-253. PubMed ID: 39326219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
    Deng Y; Wu J; Jia Q
    Med Sci Monit; 2017 Mar; 23():1254-1260. PubMed ID: 28285317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing.
    Diebold M; Kistler AD
    BMC Nephrol; 2019 Mar; 20(1):76. PubMed ID: 30823916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.